Sage Rhino Capital’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $428K | Buy |
2,305
+5
| +0.2% | +$928 | 0.09% | 143 |
|
|
2025
Q1 | $482K | Sell |
2,300
-17
| -0.7% | -$3.56K | 0.11% | 137 |
|
|
2024
Q4 | $412K | Sell |
2,317
-63
| -3% | -$11.2K | 0.09% | 148 |
|
|
2024
Q3 | $470K | Sell |
2,380
-71
| -3% | -$14K | 0.1% | 143 |
|
|
2024
Q2 | $420K | Buy |
2,451
+102
| +4% | +$17.5K | 0.1% | 140 |
|
|
2024
Q1 | $428K | Buy |
2,349
+85
| +4% | +$15.5K | 0.1% | 142 |
|
|
2023
Q4 | $351K | Sell |
2,264
-41
| -2% | -$6.35K | 0.09% | 144 |
|
|
2023
Q3 | $344K | Buy |
2,305
+28
| +1% | +$4.17K | 0.1% | 146 |
|
|
2023
Q2 | $307K | Sell |
2,277
-406
| -15% | -$54.7K | 0.09% | 157 |
|
|
2023
Q1 | $428K | Buy |
2,683
+368
| +16% | +$58.6K | 0.12% | 128 |
|
|
2022
Q4 | $374K | Sell |
2,315
-2
| -0.1% | -$323 | 0.12% | 134 |
|
|
2022
Q3 | $311K | Sell |
2,317
-171
| -7% | -$23K | 0.12% | 124 |
|
|
2022
Q2 | $381K | Sell |
2,488
-308
| -11% | -$47.2K | 0.15% | 117 |
|
|
2022
Q1 | $453K | Sell |
2,796
-35
| -1% | -$5.67K | 0.14% | 127 |
|
|
2021
Q4 | $383K | Buy |
2,831
+75
| +3% | +$10.1K | 0.11% | 137 |
|
|
2021
Q3 | $297K | Buy |
2,756
+71
| +3% | +$7.65K | 0.09% | 151 |
|
|
2021
Q2 | $302K | Buy |
2,685
+59
| +2% | +$6.64K | 0.09% | 152 |
|
|
2021
Q1 | $284K | Buy |
2,626
+40
| +2% | +$4.33K | 0.09% | 139 |
|
|
2020
Q4 | $277K | Buy |
2,586
+29
| +1% | +$3.11K | 0.11% | 137 |
|
|
2020
Q3 | $224K | Sell |
2,557
-5
| -0.2% | -$438 | 0.11% | 137 |
|
|
2020
Q2 | $252K | Buy |
+2,562
| New | +$252K | 0.13% | 124 |
|